Abstract

Review Article

A Update on Brachytherapy for Cervical Cancer: A Review

Arjun Moorthy, Ayan Issac, Ngoc-Anh Le, Kavin Mutyala*, Bhuvi Mamtani, Shyamal Patel and Lyndsay Willmott

Published: 31 October, 2025 | Volume 8 - Issue 4 | Pages: 085-091

Introduction: Cervical cancer remains one of the most common malignancies affecting women worldwide, with over 600,000 patients globally every year, and is a leading cause of cancer-related mortality in women. Although there have been advancements in both screening and prevention, radiation therapy, with or without chemotherapy, is the standard of care for treating locally advanced cervical cancer. Radiation typically consists of two methods, external beam radiation therapy (EBRT) and brachytherapy, which have both evolved in their own respective ways technologically and for patient accessibility. This article aims to review the different cervical cancer brachytherapy techniques, such as intracavitary and interstitial approaches, including their advantages and drawbacks.
Methods: Resources on PubMed between the years 2000 and 2024 were reviewed 
based on their relevance to the approaches of brachytherapy. Articles were found through the use of key terms and Boolean operators such as ("cervical cancer,” AND “brachytherapy," OR “high dose rate brachytherapy,”) OR (“intracavitary,” OR “interstitial brachytherapy,” OR “hybrid brachytherapy,”). 
Discussion: Three techniques of brachytherapy are de: intracavitary brachytherapy (ICBT), interstitial brachytherapy (ISBT), and hybrid intracavitary/interstitial brachytherapy (HBT).
Conclusion: Brachytherapy is a vital part of definitive cervical cancer treatment. While ICBT remains the standard of care for most cervical cancers, ISBT and HBT approaches remain important treatment options. HBT has been shown to address variances in patient anatomy and tumor geometry, resulting in better tumor dose coverage and improved outcomes through minimizing toxicity.

Read Full Article HTML DOI: 10.29328/journal.cjog.1001195 Cite this Article Read Full Article PDF

Keywords:

Cervical cancer; Brachytherapy; Radiation therapy; Image-guided brachytherapy; High-dose-rate brachytherapy; Interstitial brachytherapy; External Beam Radiation Therapy (EBRT); Artificial Intelligence (AI)

References

  1. Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191–203. Available from: https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(19)30482-6/fulltext
  2. Tewari KS. Cervical cancer. N Engl J Med. 2025;392(1):56–71. Available from: https://www.nejm.org/doi/full/10.1056/nejmra2404457
  3. Chino J, Annunziata CM, Beriwal S, Bradfield L, Erickson BA, Fields EC, et al. Radiation therapy for cervical cancer: executive summary of an ASTRO clinical practice guideline. Pract Radiat Oncol. 2020;10(4):220–34. Available from: https://www.practicalradonc.org/article/S1879-8500(20)30095-8/fulltext
  4. Huang CC, Ayala-Peacock DN, Stephens SJ, Chino JP. Recent advances in gynecologic radiation oncology. Cancer. 2025;131(9):e35888. Available from: https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.35888
  5. Yang X, Ren H, Li Z, Fu J. Brachytherapy for cervical cancer: from intracavitary to interstitial technique. Front Oncol. 2024;14:1442712. Available from: https://www.frontiersin.org/articles/10.3389/fonc.2024.1442712/full
  6. Banerjee R, Kamrava M. Brachytherapy in the treatment of cervical cancer: a review. Int J Womens Health. 2014;6:555–64. Available from: https://www.dovepress.com/brachytherapy-in-the-treatment-of-cervical-cancer-a-review-peer-reviewed-fulltext-article-IJWH
  7. Sturdza AE, Knoth J. Image-guided brachytherapy in cervical cancer including fractionation. Int J Gynecol Cancer. 2022;32(3):273–80. Available from: https://www.ncbi.nlm.nih.gov/
  8. Erickson B, Eifel P, Moughan J, Rownd J, Iarocci T, Owen J. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996–1999): a patterns of care study. Int J Radiat Oncol Biol Phys. 2005;63(4):1083–92. Available from: https://www.redjournal.org/article/S0360-3016(05)00588-5/fulltext
  9. Itami J, Murakami N, Watanabe M. Combined interstitial and intracavitary high-dose-rate brachytherapy of cervical cancer. Front Oncol. 2022;11:809825. Available from: https://www.frontiersin.org/articles/10.3389/fonc.2021.809825/full
  10. Tanderup K, Eifel PJ, Yashar CM, Pötter R, Grigsby PW. Curative radiation therapy for locally advanced cervical cancer: brachytherapy is NOT optional. Int J Radiat Oncol Biol Phys. 2014;88(3):537–9. Available from: https://www.redjournal.org/article/S0360-3016(13)03369-9/fulltext
  11. Han K, Milosevic M, Fyles A, Pintilie M, Viswanathan AN. Trends in the utilization of brachytherapy in cervical cancer in the United States. Int J Radiat Oncol Biol Phys. 2013;87(1):111–9. Available from: https://www.redjournal.org/article/S0360-3016(13)00667-1/fulltext
  12. Pötter R, Tanderup K, Schmid MP, Jürgenliemk-Schulz I, Haie-Meder C, Fokdal LU, et al. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study. Lancet Oncol. 2021;22(4):538–47. Available from: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(20)30753-1/fulltext
  13. Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of Radiation Therapy Oncology Group trial (RTOG) 90-01. J Clin Oncol. 2004;22(5):872–80. Available from: https://ascopubs.org/doi/10.1200/JCO.2004.07.197
  14. Tod M, Meredith WJ. Treatment of cancer of the cervix uteri, a revised Manchester method. Br J Radiol. 1953;26(305):252–7. Available from: https://www.birpublications.org/doi/10.1259/0007-1285-26-305-252
  15. Pötter R, Haie-Meder C, Van Limbergen E, Barillot I, De Brabandere M, Dimopoulos J, et al. Recommendations from gynecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervical cancer brachytherapy – 3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol. 2006;78(1):67–77. Available from: https://www.thegreenjournal.com/article/S0167-8140(05)00490-0/fulltext
  16. Datta NR. From 'points' to 'profiles' in intracavitary brachytherapy of cervical cancer. Curr Opin Obstet Gynecol. 2005;17(1):35–41. Available from: https://journals.lww.com/co-obgyn/Abstract/2005/02000/From__points__to__profiles__in_intracavitary.7.aspx
  17. Pötter R, Federico M, Sturdza A, Fotina I, Hegazy N, Schmid M, et al. Value of magnetic resonance imaging without or with applicator in place for target definition in cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys. 2016;94(3):588–97. Available from: https://www.redjournal.org/article/S0360-3016(15)03461-7/fulltext
  18. Ren J, Yuan W, Wang R, Wang Q, Li Y, Xue C, et al. Dosimetric comparison between three-dimensional magnetic resonance imaging-guided and conventional two-dimensional point A-based intracavitary brachytherapy planning for cervical cancer. PLoS One. 2016;11(9):e0161932. Available from: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0161932
  19. Serban M, Kirisits C, de Leeuw A, Pötter R, Jürgenliemk-Schulz I, Nesvacil N, et al. Ring versus ovoids and intracavitary versus intracavitary-interstitial applicators in cervical cancer brachytherapy: results from the EMBRACE I study. Int J Radiat Oncol Biol Phys. 2020;106(5):1052–62. Available from: https://www.redjournal.org/article/S0360-3016(19)34159-0/fulltext
  20. Nath R, Rivard MJ, DeWerd LA, Dezarn WA, Thompson Heaton H 2nd, Ibbott GS, et al. Guidelines by the AAPM and GEC-ESTRO on the use of innovative brachytherapy devices and applications: report of Task Group 167. Med Phys. 2016;43(6):3178–205. Available from: https://aapm.onlinelibrary.wiley.com/doi/10.1118/1.4951734
  21. Aronowitz JN. Afterloading: the technique that rescued brachytherapy. Int J Radiat Oncol Biol Phys. 2015;92(3):479–87. Available from: https://www.redjournal.org/article/S0360-3016(15)00340-2/fulltext
  22. Yoshida K, Yamazaki H, Kotsuma T, Takenaka T, Ueda MM, Miyake S, et al. Simulation analysis of optimized brachytherapy for uterine cervical cancer: can we select the best brachytherapy modality depending on tumor size? Brachytherapy. 2016;15(1):57–64. Available from: https://www.brachyjournal.com/article/S1538-4721(15)00429-0/fulltext
  23. Terahara A, Nakano T, Ishikawa A, Morita S, Tsuji H, et al. Dose-volume histogram analysis of high-dose-rate intracavitary brachytherapy for uterine cervix cancer. Int J Radiat Oncol Biol Phys. 1996;35(3):549–54. Available from: https://www.redjournal.org/article/S0360-3016(96)80018-6/fulltext
  24. Nag S, Martínez-Monge R, Ellis R, Lewandowski G, Vacarello L, Boutselis JG, et al. The use of fluoroscopy to guide needle placement in interstitial gynecological brachytherapy. Int J Radiat Oncol Biol Phys. 1998;40(2):415–20. Available from: https://www.redjournal.org/article/S0360-3016(97)00719-0/fulltext
  25. Prisciandaro JI, Zhao X, Dieterich S, Hasan Y, Jolly S, Al-Hallaq HA. Interstitial high-dose-rate gynecologic brachytherapy: clinical workflow experience from three academic institutions. Semin Radiat Oncol. 2020;30(1):29–38. Available from: https://www.sciencedirect.com/science/article/pii/S1053429619300801
  26. Nag S, Dobelbower R, Glasgow G, Gustafson G, Syed N, Thomadsen B, et al. Inter-society standards for the performance of brachytherapy: a joint report from ABS, ACMP, and ACRO. Crit Rev Oncol Hematol. 2003;48(1):1–17. Available from: https://www.sciencedirect.com/science/article/pii/S104084280300026X
  27. Pinn-Bingham M, Puthawala AA, Syed AM, Sharma A, Disaia P, Berman M, et al. Outcomes of high-dose-rate interstitial brachytherapy in the treatment of locally advanced cervical cancer: long-term results. Int J Radiat Oncol Biol Phys. 2013;85(3):714–20. Available from: https://www.redjournal.org/article/S0360-3016(12)01125-7/fulltext
  28. Bansal AK, Semwal MK, Sharma DN, Thulkar S, Julka PK, Rath GK, et al. A patient-based dosimetric study of intracavitary and interstitial brachytherapy in advanced stage carcinoma of the cervix. J Appl Clin Med Phys. 2014;15(5):4509. Available from: https://www.jacmp.org/article/10.1120/jacmp.v15i5.4509
  29. Recio FO, Piver MS, Hempling RE, Eltabbakh GH, Hahn S. Laparoscopic-assisted application of interstitial brachytherapy for locally advanced cervical carcinoma: results of a pilot study. Int J Radiat Oncol Biol Phys. 1998;40(2):411–4. Available from: https://www.redjournal.org/article/S0360-3016(97)00738-4/fulltext
  30. Oike T, Ohno T, Noda SE, Kiyohara H, Ando K, Shibuya K, et al. Can a combined intracavitary/interstitial approach be an alternative to interstitial brachytherapy with the Martinez Universal Perineal Interstitial Template (MUPIT) in computed tomography-guided adaptive brachytherapy for bulky and/or irregularly shaped gynecological tumors? Radiat Oncol. 2014;9:222. Available from: https://ro-journal.biomedcentral.com/articles/10.1186/s13014-014-0222-6
  31. Nomden CN, de Leeuw AA, Moerland MA, Roesink JM, Tersteeg RJ, Jürgenliemk-Schulz IM. Clinical use of the Utrecht applicator for combined intracavitary/interstitial brachytherapy treatment in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys. 2012;82(4):1424–30. Available from: https://www.redjournal.org/article/S0360-3016(11)00592-0/fulltext
  32. Kirisits C, Lang S, Dimopoulos J, Berger D, Georg D, Pötter R. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results. Int J Radiat Oncol Biol Phys. 2006;65(2):624–30. Available from: https://www.redjournal.org/article/S0360-3016(06)00308-1/fulltext
  33. Murakami N, Kato S, Nakano T, Uno T, Yamanaka T, Sakurai H, et al. A phase I/II clinical trial for the hybrid of intracavitary and interstitial brachytherapy for locally advanced cervical cancer. BMC Cancer. 2016;16:640. Available from: https://bmccancer.biomedcentral.com/articles/10.1186/s12885-016-2543-3
  34. Murakami N, Kobayashi K, Shima S, Tsuchida K, Kashihara T, Tselis N, et al. A hybrid technique of intracavitary and interstitial brachytherapy for locally advanced cervical cancer: initial outcomes of a single-institute experience. BMC Cancer. 2019;19:221. Available from: https://bmccancer.biomedcentral.com/articles/10.1186/s12885-019-5430-x
  35. Cordoba A, Gesta E, Escande A, Noeuveglise A, Cayez R, Halty A, et al. Interstitial needles versus intracavitary applicators only for locally advanced cervical cancer: results from real-life dosimetric comparisons. Front Oncol. 2024;14:1347727. Available from: https://www.frontiersin.org/articles/10.3389/fonc.2024.1347727/full
  36. Le NA, Patel S, Mutyala K, Issac A, Mamtani B, Willmott L. Outpatient hybrid intracavitary-interstitial brachytherapy for cervical cancer with minimal sedation in a freestanding setting. Gynecol Oncol Rep. 2025;59:101767. Available from: https://www.sciencedirect.com/science/article/pii/S2352578925000700
  37. Mutyala S, Smith G, Ansinelli H, Thawani N. Feasibility of outpatient hybrid brachytherapy for cervical cancer with minimal sedation: results from a single-institutional protocol. J Contemp Brachytherapy. 2023;15(1):43–7. Available from: https://www.termedia.pl/Feasibility-of-outpatient-hybrid-brachytherapy-for-cervical-cancer-with-minimal-sedation-results-from-a-single-institutional-protocol,54,50294,1,1.html
  38. Bélanger C, Aubin S, Lavallée MC, Beaulieu L. Simultaneous catheter and multicriteria optimization for HDR cervical cancer brachytherapy with a complex intracavity/interstitial applicator. Med Phys. 2024;51(5):2128–43. Available from: https://aapm.onlinelibrary.wiley.com/doi/10.1002/mp.16874
  39. Varela Cagetti L, Gonzague-Casabianca L, Zemmour C, Lambaudie E, Houvenaeghel G, Provansal M, et al. The impact of modern preoperative high-dose-rate brachytherapy in early-stage cervical cancer. Gynecol Oncol. 2021;161(1):166–72. Available from: https://www.sciencedirect.com/science/article/pii/S0090825821000418
  40. Arya R, Giurcanu M, Jutzy JM, Peters P, Daily EW, Golden DW, et al. Local control and use of external beam parametrial boost in the era of image-guided brachytherapy for locally advanced cervical cancer. Am J Clin Oncol. 2021;44(11):565–71. Available from: https://journals.lww.com/amjclinicaloncology/Fulltext/2021/11000/Local_Control_and_Use_of_External_Beam_Parametrial.6.aspx
  41. Syed AM, Puthawala AA, Abdelaziz NN, el-Naggar M, Disaia P, Berman M, et al. Long-term results of low-dose-rate interstitial-intracavitary brachytherapy in the treatment of carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2002;54(1):67–78. Available from: https://www.redjournal.org/article/S0360-3016(02)02900-0/fulltext
  42. Viswanathan AN, Beriwal S, De Los Santos JF, Demanes DJ, Gaffney D, Hansen J, et al. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy. Brachytherapy. 2012;11(1):47–52. Available from: https://www.brachyjournal.com/article/S1538-4721(11)00321-5/fulltext
  43. Demanes DJ, Rodriguez RR, Bendre DD, Ewing TL. High dose rate transperineal interstitial brachytherapy for cervical cancer: high pelvic control and low complication rates. Int J Radiat Oncol Biol Phys. 1999;45(1):105–12. Available from: https://www.redjournal.org/article/S0360-3016(99)00124-8/fulltext
  44. Schwarz JK, Beriwal S, Esthappan J, Erickson B, Feltmate C, Fyles A, et al. Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer. Brachytherapy. 2015;14(5):587–99. Available from: https://www.brachyjournal.com/article/S1538-4721(15)00216-1/fulltext
  45. Ka K, Laville A, Rassy E, El Ayachi R, Pautier P, Ba MB, et al. Image-guided adaptive brachytherapy for advanced cervical cancer spreading to the bladder and/or rectum: clinical outcome and prognostic factors. Gynecol Oncol. 2023;168:32–8. Available from: https://www.sciencedirect.com/science/article/pii/S0090825822007284
  46. Callaghan CM, Adams Q, Flynn RT, Wu X, Xu W, Kim Y. Systematic review of intensity-modulated brachytherapy (IMBT): static and dynamic techniques. Int J Radiat Oncol Biol Phys. 2019;105(1):206–21. Available from: https://www.redjournal.org/article/S0360-3016(19)30977-3/fulltext
  47. Welsh JS, Limmer JP, Howard SP, Diamond D, Harari PM, Tome W. Precautions in the use of intensity-modulated radiation therapy. Technol Cancer Res Treat. 2005;4(2):203–10. Available from: https://journals.sagepub.com/doi/10.1177/153303460500400209
  48. Soror T, Siebert FA, Lancellotta V, Placidi E, Fionda B, Tagliaferri L, et al. Quality assurance in modern gynecological HDR-brachytherapy (interventional radiotherapy): clinical considerations and comments. Cancers (Basel). 2021;13(4):912. Available from: https://www.mdpi.com/2072-6694/13/4/912
  49. Prisciandaro J, Zoberi JE, Cohen G, Kim Y, Johnson P, Paulson E, et al. AAPM task group report 303 endorsed by the ABS: MRI implementation in HDR brachytherapy—considerations from simulation to treatment. Med Phys. 2022;49(8):e983–1023. Available from: https://aapm.onlinelibrary.wiley.com/doi/10.1002/mp.15713
  50. Shi J, Chen J, He G, Peng Q. Artificial intelligence in high-dose-rate brachytherapy treatment planning for cervical cancer: a review. Front Oncol. 2025;15:1507592. Available from: https://www.frontiersin.org/articles/10.3389/fonc.2025.1507592/full 

Figures:

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?